A Case of Drug-Induced Liver Injury Secondary to Natalizumab.

Phillip Pasquale SantoiemmaHaripriya MaddurChristopher M Moore

Published in: Case reports in hepatology (2020)

A 33-year-old Caucasian female with relapsing-remitting multiple sclerosis presented with abdominal pain, nausea, and vomiting and was found to have acute liver injury. After thorough investigation, she was diagnosed with drug-induced liver injury (DILI) thought secondary to redosing of Natalizumab therapy.

Keyphrases

multiple sclerosis
drug induced
liver injury
abdominal pain
white matter
adverse drug
emergency department
liver failure
rheumatoid arthritis
systemic lupus erythematosus
hepatitis b virus
respiratory failure
acute respiratory distress syndrome